microdosing tirzepatide vs semaglutide THE GLP-1 PROGRAM The GLP-1s-Semaglutide, Tirzepatide & Retatrutide:

This is 40 times the standard subcutaneous dose, suggesting a wide safety margin

We do not know how weight would have changed in these participants had they not been receiving the drug

So, while you might feel a slight difference in the first week or two, the complete appetite control tends to kick in over a month or more, depending on your dose, your body, and how you respond

These risks can vary in severity, from severe vision loss and blindness to intestinal blockages and many other serious health conditions

It will take plenty more time and research, including early successful clinical trials in humans, before BRP should be seen as the next big thing in obesity treatment

The weight loss timeline for semaglutide shows that most people resume losing weight once they reach therapeutic doses, typically by weeks 8 to 12